Strovite One Tablet
FDA Label NDC 0642-0207

13 label sections · Submitted to the FDA by Exeltis Usa, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Exeltis Usa, Inc. for the product Strovite One (NDC 0642-0207). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, composition, indications and usage, contraindications, warning/precautions, drug interactions, information for patients, pediatric use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Information For Patients

Patients should be counseled to disclose all medical conditions, including use of all medications, vitamins and supplements, pregnancy, and breastfeeding.

Pediatric Use

Not recommended for pediatric use.

Dosage And Administration

One caplet daily or as directed by a physician.

* Please review the disclaimer below.